Mirae Asset Global Investments Co., Ltd. Summit Therapeutics Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $22.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 26,205 shares of SMMT stock, worth $622,630. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26,205
Previous 20,958
25.04%
Holding current value
$622,630
Previous $163,000
251.53%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding SMMT
# of Institutions
199Shares Held
76MCall Options Held
2.01MPut Options Held
2.84M-
Baker Bros. Advisors LP New York, NY24.4MShares$580 Million5.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.9MShares$260 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$188 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.44MShares$129 Million0.01% of portfolio
-
State Street Corp Boston, MA3.47MShares$82.4 Million0.0% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $4.78B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...